How is GH secretion measured in preclinical research?

Pituitary GH secretion is typically measured in rodent models by catheterization of the jugular or carotid vessels for serial blood sampling at 5 to 20-minute intervals to capture the pulsatile GH secretion profile. GH concentration in plasma samples is measured by species-specific radioimmunoassay or ELISA. Software such as Deconvolution and Pulse analysis algorithms analyze the resulting GH concentration-time series to extract pharmacokinetic parameters including pulse amplitude, pulse frequency, pulse duration, and interpulse basal GH. Downstream IGF-1 is measured as an integrated GH secretory marker.

What is somatopause and why is it relevant to GHS research?

Somatopause refers to the age-related decline in GH secretion that occurs in most mammals, including humans, typically beginning in the third or fourth decade of life. The decline involves reduced GHRH pulse amplitude, increased somatostatin tone, and impaired pituitary GH secretory capacity. Research examining growth hormone secretagogues such as Tesamorelin and CJC-1295/Ipamorelin in aging animal models is partly motivated by the somatopause phenomenon: these compounds are studied for their capacity to partially restore GH pulse amplitude in aged preclinical models and to examine the downstream metabolic consequences of GH axis augmentation in an aging biological context.

Compound

Growth Hormone

A 191-amino acid polypeptide hormone secreted by the pituitary gland that regulates growth, metabolism, and body composition studied in preclinical endocrinology research.

Definition

Growth hormone (GH, somatotropin) is a 191-amino acid single-chain polypeptide hormone produced and secreted by somatotroph cells in the anterior pituitary gland in response to GHRH stimulation. GH is secreted in discrete pulses driven by the hypothalamic GHRH-somatostatin axis. It acts on peripheral tissues either directly through GH receptors or indirectly through stimulation of IGF-1 production in the liver. GH promotes linear growth in developing organisms, stimulates lipolysis in adipose tissue, promotes muscle protein synthesis, and has metabolic effects on glucose metabolism. GH secretion declines with age, a phenomenon studied in the context of somatopause research.

Research Context

Growth hormone is the downstream effector studied in growth hormone axis research involving compounds such as Tesamorelin, CJC-1295/Ipamorelin, and AOD-9604. Research models examining GH axis modulation measure GH pulse amplitude and frequency by serial blood sampling, downstream IGF-1 as an integrated GH activity marker, and metabolic outcomes including body fat distribution and lean mass. AOD-9604, a fragment of the GH C-terminus, is specifically studied for its lipolytic properties and is examined as a research tool for isolating specific GH-like metabolic effects without full GH receptor activation.

Relevant Compounds

This term applies to the following research compound hubs.

tesamorelinView hub →cjc ipaView hub →aod 9604View hub →

Frequently Asked Questions

Explore the Research Library

Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.

Research Library →All Glossary Terms ↑

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research